Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1985 7
1986 1
1987 2
1988 1
1990 1
1991 1
1992 1
1993 1
1994 2
1996 2
1997 3
1999 3
2000 1
2001 1
2002 2
2003 3
2004 1
2005 5
2006 8
2007 5
2008 7
2009 4
2010 10
2011 4
2012 4
2013 5
2014 1
2015 3
2017 2
2018 2
2019 4
2020 6
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C. Venook AP, et al. Among authors: atkins jn. JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105. JAMA. 2017. PMID: 28632865 Free PMC article. Clinical Trial.
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Fehrenbacher L, Cecchini RS, Geyer CE Jr, Rastogi P, Costantino JP, Atkins JN, Crown JP, Polikoff J, Boileau JF, Provencher L, Stokoe C, Moore TD, Robidoux A, Flynn PJ, Borges VF, Albain KS, Swain SM, Paik S, Mamounas EP, Wolmark N. Fehrenbacher L, et al. Among authors: atkins jn. J Clin Oncol. 2020 Feb 10;38(5):444-453. doi: 10.1200/JCO.19.01455. Epub 2019 Dec 10. J Clin Oncol. 2020. PMID: 31821109 Free PMC article. Clinical Trial.
PCA pump.
Atkins JN. Atkins JN. Palliat Med. 1993;7(1):77. Palliat Med. 1993. PMID: 8287203 No abstract available.
Schistocytes in erythroleukemia.
Atkins JN, Muss HB. Atkins JN, et al. Am J Med Sci. 1985 Mar;289(3):110-3. doi: 10.1097/00000441-198503000-00004. Am J Med Sci. 1985. PMID: 3856384
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis.
McCleary NJ, Zhang S, Ma C, Ou FS, Bainter TM, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. McCleary NJ, et al. Among authors: atkins jn. J Geriatr Oncol. 2022 May;13(4):469-479. doi: 10.1016/j.jgo.2022.01.006. Epub 2022 Jan 31. J Geriatr Oncol. 2022. PMID: 35105521 Free PMC article.
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB 3rd, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. Guercio BJ, et al. Among authors: atkins jn. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33426464 Free PMC article. Clinical Trial.
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors.
Hong DS, Rixe O, Chiu VK, Forde PM, Dragovich T, Lou Y, Nayak-Kapoor A, Leidner R, Atkins JN, Collaku A, Fox FE, Marshall MA, Olszanski AJ. Hong DS, et al. Among authors: atkins jn. Clin Cancer Res. 2022 Feb 1;28(3):479-488. doi: 10.1158/1078-0432.CCR-21-2781. Epub 2021 Nov 9. Clin Cancer Res. 2022. PMID: 34753777 Free PMC article. Clinical Trial.
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS. Vassilakopoulou M, et al. Among authors: atkins jn. Oncology. 2021;99(9):580-588. doi: 10.1159/000516168. Epub 2021 May 6. Oncology. 2021. PMID: 33957633 Free PMC article.
Magic lessons..
Atkins JN. Atkins JN. South Med J. 1992 Nov;85(11):1153. doi: 10.1097/00007611-199211000-00025. South Med J. 1992. PMID: 1439961 No abstract available.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
Bear HD, Tang G, Rastogi P, Geyer CE Jr, Robidoux A, Atkins JN, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Swain SM, Mamounas EP, Wolmark N. Bear HD, et al. Among authors: atkins jn. N Engl J Med. 2012 Jan 26;366(4):310-20. doi: 10.1056/NEJMoa1111097. N Engl J Med. 2012. PMID: 22276821 Free PMC article. Clinical Trial.
99 results